Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) — The “United States Diagnostics Market, Competition, Forecast and Opportunities, 2018-2028” report has been added to ResearchAndMarkets.com’s offering.
The United States Diagnostics Market is projected to witness significant growth between 2018 and 2028, with a Compound Annual Growth Rate (CAGR) of 8.93% through 2028, as per a comprehensive market analysis. Valued at USD 35.66 Billion in 2022, the market’s expansion is propelled by a variety of factors, including advancements in diagnostic technologies and an increased focus on personalized healthcare.
Rising Demand for Advanced Diagnostics in the United States
There has been a surge in the utilization of cutting-edge diagnostic tests owing to the escalating burden of infectious and chronic diseases. An increasing number of healthcare providers are now adopting automated platforms that offer more accurate, reliable, and time-efficient diagnostic procedures. The recent pandemic has laid bare the importance of prompt and accurate diagnostics in managing infectious diseases and controlling outbreaks. Furthermore, the adoption of newer technologies such as next-generation sequencing, liquid biopsy, and AI-driven diagnostic solutions has further solidified the imperative role of diagnostics in modern healthcare.
Technological Innovations Underpinning Market Growth
The integration of advanced technologies like artificial intelligence (AI) and machine learning is revolutionizing the diagnostics landscape of the United States. These innovations aid in the earlier detection of diseases and the delivery of customized treatment plans. Additionally, the shift towards Point-Of-Care Testing (POCT) has been instrumental in enhancing the efficiency of patient management strategies. The digital transformation of pathology, including the advent of digital pathology platforms and their increasing adoption across the United States, is facilitating improvements in the quality and speed of diagnoses.
Segmental Insights: Regional Dominance and Market Performance
The Northeast region is anticipated to maintain its dominance in the United States Diagnostics Market because of its robust healthcare infrastructure, notable healthcare spending, and the presence of industry-leading companies. Reagents are projected to remain at the forefront of product type demand, as they are essential in a plethora of diagnostic applications. Moreover, Infectious Disease Testing is expected to lead the Type of Test segment, due to the heightened need for rapid and accurate diagnostic tools in light of recent infectious disease outbreaks.
- Product Types: Reagents are essential to a wide array of diagnostic platforms such as immunodiagnostics and molecular diagnostics.
- Type of Test: Infectious Disease Testing is emerging as the largest segment as technological advancements lead to more efficient testing methods.
- End User: Hospitals, public labs, and diagnostic centers continue to be primary users in the diagnostics market.
With the healthcare landscape continually evolving, diagnostic companies are challenged to innovate and provide affordable and efficient diagnostic solutions. The industry faces hurdles such as the complexity of reimbursement scenarios, which could impact demand. Nonetheless, the soaring development of user-friendly diagnostic devices and the incorporation of digital pathology are setting the stage for a more connected and efficient healthcare system in the United States.
In essence, the United States Diagnostics Market is on a trajectory of growth and innovation, with a focus on enhancing the accessibility and quality of healthcare services through cutting-edge diagnostic solutions. As the industry moves forward, it is expected to continue making strides in improving patient outcomes and disease management strategies.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 84 |
| Forecast Period | 2022 – 2028 |
| Estimated Market Value (USD) in 2022 | $35.66 Billion |
| Forecasted Market Value (USD) by 2028 | $59.9 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | United States |
Report Scope:
In this report, the United States Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
United States Diagnostics Market, By Product Type:
- Reagents
- Instruments
- Software & Services
United States Diagnostics Market, By Type of Test:
- Infectious Disease Testing
- Lipid Panel
- Metabolic Panel
- Others
United States Diagnostics Market, By Technique:
- Immunodiagnostics
- Clinical Techniques
- Molecular Diagnostics
- Tissue Diagnostics
- Others
United States Diagnostics Market, By Usability:
United States Diagnostics Market, By Application:
- Infectious Diseases Cancer
- Sexually Transmitted Diseases
- Others
United States Diagnostics Market, By End User:
- Hospitals
- Public labs
- Diagnostic Centers
- Point-of-Care Testing Centers
- Private or Commercial Laboratories
- Others
United States Diagnostics Market, By Region:
- Northeast Region
- Midwest Region
- West Region
- South Region
Company Profiles
- Abbott Laboratories, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson & Johnson
- Ortho-Clinical Diagnostics, Inc.
- Becton, Dickinson, and Company
- Bio-Rad Laboratories, Inc.
- Roche Diagnostics Corporation
- Siemens Medical Solutions USA, Inc.
- Biomerieux Inc.
For more information about this report visit https://www.researchandmarkets.com/r/x5pkm1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
